Pharmaceutical Research and Manufacturers of America

Short of a single-payer system, here are three ways we could greatly improve both the availability and the affordability of health insurance.
"It’s hard to view this as anything but a substantial win for pharma."
Documents examined by Kaiser Health News shed light on the workings of the Trump administration's “Drug Pricing and Innovation Working Group."